Search

Your search keyword '"Platinum resistant"' showing total 14 results

Search Constraints

Start Over You searched for: Descriptor "Platinum resistant" Remove constraint Descriptor: "Platinum resistant" Publisher academic press inc. Remove constraint Publisher: academic press inc.
14 results on '"Platinum resistant"'

Search Results

1. A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer.

2. Aberrant expression of TMEM205 signaling promotes platinum resistance in ovarian cancer: An implication for the antitumor potential of DAP compound.

3. The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community.

4. New approaches for targeting platinum-resistant ovarian cancer.

5. Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancer

6. HIPEC after neoadjuvant chemotherapy and interval debulking is associated with development of platinum-refractory or -resistant disease.

7. Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer.

8. Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial.

9. “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?

10. Referrals to phase I clinical trials in a gynecologic oncology unit.

11. Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group

12. A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer

13. Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: A phase II trial of the Puget Sound Oncology Consortium

14. Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer

Catalog

Books, media, physical & digital resources